Heart Failure - ANTHEM-HFrEF Pivotal Study

Autonomic Regulation Therapy to Enhance Myocardial Function and Reduce Progression of Heart Failure with Reduced Ejection Fraction (ANTHEM-HFrEF Pivotal Study)

Dr. Joseph  Radojevic is the Principal Investigator of the ANTHEM Trial which will try to determine whether Autonomic Regulation Therapy (ART) in addition to medical therapy is safe and more effective than medical therapy alone for the treatment of heart failure. 


  • Stable symptomatic Heart Failure with a hospitalization within the last 6 months
  • currently in sinus rhythm

Please contact Khadija El Aoudi at 860-972-3167 or by email at Khadija.elaoudi@hhchealth.org for more information